NCT05578105View on ClinicalTrials.gov

Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

RecruitingOBSERVATIONAL
Enrollment

650

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Autoimmune Polyendocrine Syndrome Type II
Interventions
OTHER

no intervention

No intervention, only observation

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER